pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 7·1 min read
save

Digital health firms eye CMS ACCESS Medicare pilot despite modest reimbursement

Jul 7, 2026·read at Endpoints ↗RegulatoryNeutral

A new Medicare initiative called CMS ACCESS is being launched to manage chronic diseases among seniors.

The program will contract digital health companies to provide remote monitoring and other services, but the reimbursement rates are low, roughly equivalent to the revenue from a few patient visits with commercial insurers.

Analysts note that while the pilot offers a pathway for digital health firms to enter the Medicare market, the modest payments may limit the financial incentive for many companies.

The experiment could shape how digital health tools are integrated into senior care, and stakeholders will watch the outcomes to assess scalability and sustainability.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “How digital health companies are planning to conquer CMS ACCESS”

read at Endpoints ↗
86 words · retrieved Jul 8
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoExclusive: Astellas partners with Boston ‘miniproteins’ startupEndpoints
  • 2h agoRapport says drug it licensed from J&J clears Phase 2 bipolar mania studyEndpoints
  • 18h agoFormer MIT professor David Sabatini awarded $6M in defamation caseEndpoints
  • 18h agoAntheia gets $80M conditional DOD loan to onshore to the USEndpoints
  • 20h ago#ESMO26 regular abstracts featuring Zai Lab, GSK, Merck and moreEndpoints